The synthesis and characterization of neutral tricarbonyl fac-[Re/99mTc(quin)(X)(CO)3] and dicarbonyl cis–trans-[Re/99mTc(quin)(X)2(CO)2] mixed ligand complexes with quinaldic acid (quin) as the bidentate ligand and trimethoxyphosphine [P(OCH3)3], tris(hydroxymethyl)-phosphine [P(CH2OH)3], triphenylphosphine (PPh3), and triphenylarsine (AsPh3) as the monodentate ligands (X) is described. The synthesis of the [2 + 1] tricarbonyl complexes proceeds by displacement of the water molecule of the fac-[Re/99mTc(quin)(H2O)(CO)3] by the monodentate ligand. Interestingly, the synthesis of the [2 + 1 + 1] dicarbonyl complexes was achieved only for PPh3 after replacing the CO group trans to PPh3 with a second PPh3 molecule. The latter complex was also obtained by refluxing quinaldic acid with the trans-mer-[Re(PPh3)2(Cl)(CO)3] precursor in toluene. Rhenium complexes were prepared in satisfactory yields and fully characterized. At the technetium-99 m level, complexes were produced in high radiochemical yields and characterized by comparative chromatographic analysis using the analogous rhenium complexes. Complexes have shown varying stability against transchelation by cysteine and histidine in agreement with the decreasing σ-donating capacity of the monodentate ligand (P(OCH3)3 > P(CH2OH)3 > PPh3 > AsPh3. The stable complexes with PPh3 showed high lipophilicity (LogP 2.90 and 3.10, respectively) due to the lipophilic nature of the monodentate ligands. The σ-donor and π-acceptor capacity of the monodentate ligand strongly influences the formation and stability of the complexes, and these characteristics should be considered before choosing the appropriate ligand for radiopharmaceuticals design.
Read full abstract